BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26485247)

  • 1. Complement Split Products C3a/C5a and Receptors: Are They Regulated by Circulating Angiotensin II Type 1 Receptor Autoantibody in Severe Preeclampsia?
    Ye Y; Kong Y; Zhang Y
    Gynecol Obstet Invest; 2016; 81(1):28-33. PubMed ID: 26485247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat.
    Regal JF; Strehlke ME; Peterson JM; Wing CR; Parker JE; Nieto NF; Bemis LT; Gilbert JS; Fleming SD
    Mol Immunol; 2016 Oct; 78():38-47. PubMed ID: 27588825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of complement 3a receptor (C3aR) in human placentas from severe preeclamptic pregnancies.
    Lim R; Lappas M
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):194-8. PubMed ID: 22901903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and significance of AT1-AA and ET1 in materal peripheral blood, umbilical cord blood and placenta in preeclampsia].
    Zhao XL; Liu Z; Liu C
    Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):721-5. PubMed ID: 23302726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II Type I Receptor Agonistic Autoantibody Induces Podocyte Injury via Activation of the TRPC6- Calcium/Calcineurin Pathway in Pre-Eclampsia.
    Yu Y; Zhang L; Xu G; Wu Z; Li Q; Gu Y; Niu J
    Kidney Blood Press Res; 2018; 43(5):1666-1676. PubMed ID: 30380548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia.
    Wang W; Irani RA; Zhang Y; Ramin SM; Blackwell SC; Tao L; Kellems RE; Xia Y
    Hypertension; 2012 Sep; 60(3):712-21. PubMed ID: 22868393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin type 1 receptor autoantibody from preeclamptic patients induces human fetoplacental vasoconstriction.
    Zhang S; Zheng R; Yang L; Zhang X; Zuo L; Yang X; Bai K; Song L; Tian J; Yang J; Liu H
    J Cell Physiol; 2013 Jan; 228(1):142-8. PubMed ID: 22566240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II type 1 receptor autoantibody as a novel regulator of aldosterone independent of preeclampsia.
    Yang J; Li L; Shang JY; Cai L; Song L; Zhang SL; Li H; Li X; Lau WB; Ma XL; Liu HR
    J Hypertens; 2015 May; 33(5):1046-56. PubMed ID: 25693057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.
    Liu L; Zhang Y; Duan X; Peng Q; Liu Q; Zhou Y; Quan S; Xing G
    J Clin Immunol; 2014 Feb; 34(2):224-32. PubMed ID: 24327134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia.
    Stepan H; Faber R; Wessel N; Wallukat G; Schultheiss HP; Walther T
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2424-7. PubMed ID: 16569734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auto-antibodies against the angiotensin II type I receptor in women with uteroplacental acute atherosis and preeclampsia at delivery and several years postpartum.
    Rieber-Mohn AB; Sugulle M; Wallukat G; Alnæs-Katjavivi P; Leite Størvold G; Bolstad N; Redman CW; Dechend R; Staff AC
    J Reprod Immunol; 2018 Aug; 128():23-29. PubMed ID: 29843114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study.
    Herse F; Verlohren S; Wenzel K; Pape J; Muller DN; Modrow S; Wallukat G; Luft FC; Redman CW; Dechend R
    Hypertension; 2009 Feb; 53(2):393-8. PubMed ID: 19064815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the anaphylatoxin receptors, complement anaphylatoxin 3a receptor and complement anaphylatoxin 5a receptor, in the nasal mucosa of patients with mild and severe persistent allergic rhinitis.
    Jun SW; Kim TH; Lee HM; Lee SH; Kim WJ; Park SJ; Kim YS; Lee SH
    J Allergy Clin Immunol; 2008 Jul; 122(1):119-25. PubMed ID: 18538384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody against angiotensin AT1 receptor from preeclamptic patients enhances collagen-induced human platelet aggregation.
    Bai K; Wang K; Li X; Wang J; Zhang J; Song L; Wang J; Zhang S; Lau WB; Ma X; Liu H
    Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):749-55. PubMed ID: 23681235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
    Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
    Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadmium-induced immune abnormality is a key pathogenic event in human and rat models of preeclampsia.
    Zhang Q; Huang Y; Zhang K; Huang Y; Yan Y; Wang F; Wu J; Wang X; Xu Z; Chen Y; Cheng X; Li Y; Jiao J; Ye D
    Environ Pollut; 2016 Nov; 218():770-782. PubMed ID: 27511439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation.
    Yang X; Wang F; Chang H; Zhang S; Yang L; Wang X; Cheng X; Zhang M; Ma XL; Liu H
    J Hypertens; 2008 Aug; 26(8):1629-35. PubMed ID: 18622242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of anaphylatoxin receptors on platelets in patients with coronary heart disease.
    Patzelt J; Mueller KA; Breuning S; Karathanos A; Schleicher R; Seizer P; Gawaz M; Langer HF; Geisler T
    Atherosclerosis; 2015 Feb; 238(2):289-95. PubMed ID: 25544179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
    Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
    Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.